# OnCo record nct07525206 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07525206/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07525206", "NCT07525206" ;
  schema:name "A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer"@en ;
  schema:alternateName "AndroMETa-CRC"@en ;
  schema:description "A phase 3 trial testing Telisotuzumab adizutecan in colorectal cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07525206/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07525206> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2026-05-22" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/telisotuzumab-adizutecan/> ;
  onco:companies <https://onco.cc/companies/abbvie/> .